Found: 17
Select item for more details and to access through your institution.
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 9, p. 3925, doi. 10.1172/JCI65745
- By:
- Publication type:
- Article
Immunotherapy Following Regional Chemotherapy Treatment of Advanced Extremity Melanoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 8, p. 2525, doi. 10.1245/s10434-014-3671-0
- By:
- Publication type:
- Article
Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo.
- Published in:
- Nature Medicine, 2005, v. 11, n. 2, p. 130, doi. 10.1038/nm1183
- By:
- Publication type:
- Article
Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 475, doi. 10.1007/s00262-020-02698-2
- By:
- Publication type:
- Article
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02876
- By:
- Publication type:
- Article
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4753, doi. 10.3390/cancers13194753
- By:
- Publication type:
- Article
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 19, p. 19394, doi. 10.1002/cam4.6532
- By:
- Publication type:
- Article
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adi4191
- By:
- Publication type:
- Article
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Updates in adjuvant systemic therapy for melanoma.
- Published in:
- Journal of Surgical Oncology, 2019, v. 119, n. 2, p. 222, doi. 10.1002/jso.25298
- By:
- Publication type:
- Article
Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.
- Published in:
- Abdominal Radiology, 2016, v. 41, n. 2, p. 207, doi. 10.1007/s00261-015-0560-3
- By:
- Publication type:
- Article
425. Translation of Enhanced Dendritic Cell Vaccines Using a CID-Inducible CD40 Receptor<sup>*</sup>.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S163, doi. 10.1016/j.ymthe.2006.08.490
- By:
- Publication type:
- Article
Role of dendritic cell metabolic reprogramming in tumor immune evasion.
- Published in:
- International Immunology, 2020, v. 32, n. 7, p. 485, doi. 10.1093/intimm/dxaa036
- By:
- Publication type:
- Article
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 672, p. 1, doi. 10.1126/scitranslmed.abq7019
- By:
- Publication type:
- Article
Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors.
- Published in:
- Frontiers in Immunology, 2015, v. 5, p. 1, doi. 10.3389/fimmu.2014.00673
- By:
- Publication type:
- Article
Early carcinogenesis involves the establishment of immune privilege via intrinsic and extrinsic regulation of indoleamine 2,3-dioxygenase-1: translational implications in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00438
- By:
- Publication type:
- Article